CD40 mAb is shown to induce anti‐tumor immune response and turn the immunosuppressive environment to a more immunogenic TIME.[48] Our results are supportive of this, where we observed DC activation, enhanced CD8+ T cells priming and CD4+ Tregs inhibition (Figure 3). This evidence concerns the gene CD4 and neoplasm.